Abrus Bio key facts
as of Oct 2026- The company is currently operating in Stealth mode.
- Abrus Bio is valued at approximately $31.5M as of Oct 2026 (last reported valuation).
- It has raised $19.5M; the latest was Early Stage VC ($15.0M) in Sep 2025.
- Notable investors include Paladin Capital Group, General Inception, Vensana Capital.
- Status: Privately Held (backing).
Last reported valuation
LOW confidence$31.5M
Abrus Bio's last reported valuation, Sep 2025. Nothing priced has surfaced since.
Free account
More of Abrus Bio with a free account
- ·Watch Abrus Bio: the Monday email on marks, rounds and moves
Abrus Bio funding rounds
No rounds on record
No funding rounds for Abrus Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
Who backs Abrus Bio
3Abrus Bio valuation
Abrus Bio's last reported valuation was $31.5 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Abrus Bio investors
3 investors are on record for Abrus Bio, including Paladin Capital Group, General Inception and Vensana Capital.
About Abrus Bio
The company is currently operating in Stealth mode.
- Sector
- Business Products and Services (B2B)
- HQ
- San Diego, CA, United States
- Founded
- 2022
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.